Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	May 04, 2013	Apr. 28, 2012
Cash flows from operating activities:
Net loss	$ (5,830)	$ (13,075)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of deferred financing costs	224	224
Depreciation and amortization	3,246	1,934
(Recovery) provision for losses on accounts receivable	(31)	(43)
Share-based compensation expense	102	3,806
Change in operating assets and liabilities net of effect of acquisition:
Accounts receivable	(9,311)	7,451
Inventories	(7,547)	584
Prepaid expenses and other assets	9,144	3,670
Accounts payable	(7,036)	2,103
Accounts payable-affiliates	1,527	(8,382)
Accrued expenses and other liabilities and other long-term liabilities	(2,243)	410
Net cash used in operating activities	(17,755)	(1,318)
Cash flows from investing activities:
Additions to property and equipment	(1,666)	(1,353)
Payment to acquire Parlux, net of Parlux cash on hand of $17,114	0	(44,949)
Net cash used in investing activities	(1,666)	(46,302)
Cash flows from financing activities:
Net borrowings under bank line of credit	18,587	18,527
Borrowings under affiliated notes payable to fund Parlux acquisition	0	30,000
Principal payments under capital lease obligations	(205)	(265)
Proceeds from exercise of stock options	31	4
Net cash provided by financing activities	18,413	48,266
Net (decrease) increase in cash and cash equivalents	(1,008)	646
Cash and cash equivalents at beginning of period	2,447	1,682
Cash and cash equivalents at end of period	1,439	2,328
Supplemental Information:
Cash paid during the period for Interest	538	322
Cash paid during the period for Income taxes	0	66
Fair value of equity consideration given to acquire Parlux	$ 0	$ 83,595